Medicare would pay for skin substitute wound products using one national rate and one billing code. High-billing providers would face extra reviews before payment and prior approval rules. The FDA would also review how to speed up some tissue-product approvals without lowering safety standards.
Modern Action explains what the legislation does, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Advanced Wound Care and Regenerative Medicine Access and Reform Act is a House bill in committee. The latest recorded action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Latest action on H.R. 6852: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Who this affects: This bill mainly affects Medicare patients who need advanced wound care, the clinicians who treat them, and companies that make skin substitute or regenerative medicine products. Patients could see more consistent Medicare payment rules, but some care could take longer when prior authorization applies. Providers with very high Medicare billing for these products would face the biggest new oversight. Manufacturers and tissue banks could be affected by future Food and Drug Administration guidance on human cell and tissue product approvals.
Why this matters: Medicare now pays for skin substitute wound products in ways that can vary by product and care setting. This bill would make payment more uniform and add stronger checks on high-billing providers. That could reduce waste or fraud, but it could also add paperwork and delays for some wound-care practices. The FDA review could help some regenerative medicine products move through review faster, depending on how the agency carries it out.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Keep acting on Modern Action
Compare the broader issue and related bills without leaving Modern Action.
Officially: Advanced Wound Care and Regenerative Medicine Access and Reform Act
Medicare would pay for skin substitute wound products using one national rate and one billing code. High-billing providers would face extra reviews before payment and prior approval rules. The FDA would also review how to speed up some tissue-product approvals without lowering safety standards.
Use this page to support, oppose, or ask Congress to amend HR6852. Modern Action explains what the bill does, helps identify the right senators or representative, and drafts a bill-specific message you can edit and send.
Where it stands
Sitting in Energy and Commerce
No vote scheduled. Constituent contact is what moves bills out of committee.
↓ Why your message matters here
This bill is sitting in committee with no scheduled vote — which means a small number of constituent messages can decide whether it moves forward or quietly dies.
Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.
Where this bill is in the process
Introduced
Introduced in House
House Committee
Under House committee consideration
Latest: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (12/18/2025)
House Floor Vote
Voted on by House
Passed House
Approved by House
Senate Review
Sent to Senate for consideration
Passed Both Chambers
Approved by both House and Senate
Signed into Law
Signed by the President
For more detail
Choose one clear position: support, oppose, or amend. Then pick any reasons or personal context you want included. Modern Action uses that input and the bill context to draft a message you can edit and send.
Congressional offices prioritize messages from their own constituents. Modern Action uses your address to route the drafted message to your House representative when that is the most relevant target for this bill.
The draft includes the bill number, your position, the reasons you selected, any personal context you added, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes. You stay in control because you can edit the message before sending.
This page gives you an opportunity to support, oppose, or ask for changes to Advanced Wound Care and Regenerative Medicine Access and Reform Act, then contact the elected officials who can act. Modern Action drafts the message from your position and the reasons you select.
Modern Action keeps the action tied to the bill itself: what it does, where it is in the process (committee), which office can still act, and what ask belongs in the message.
You are not starting from a blank form. Modern Action drafts the message around HR6852, your stance, and the reasons you choose, then lets you edit and send when ready.
